Elicio Therapeutics, Inc. (ELTX)
2.55
-0.01
(-0.39%)
USD |
NASDAQ |
Sep 02, 16:00
2.565
+0.02
(+0.59%)
After-Hours: 20:00
Elicio Therapeutics Cash from Operations (Annual) : -36.95M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -36.95M |
| December 31, 2024 | -37.07M |
| December 31, 2023 | -32.69M |
| December 31, 2022 | -22.18M |
| December 31, 2021 | -52.64M |
| December 31, 2020 | -22.89M |
| December 31, 2019 | -24.59M |
| Date | Value |
|---|---|
| December 31, 2018 | -8.02M |
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | 1.892M |
| December 31, 2012 | 1.065M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Precigen, Inc. | -87.83M |
| Agenus, Inc. | -77.20M |
| Amgen, Inc. | 9.958B |
| Anika Therapeutics, Inc. | 11.19M |
| BioCryst Pharmaceuticals, Inc. | 329.88M |